SBBP - Strongbridge Biopharma plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
20,620
18,027
7,046
-
Cost of Revenue
3,961
3,986
1,483
-
Gross Profit
16,659
14,041
5,563
-
Operating Expenses
Research Development
30,783
25,441
37,991
35,851
Selling General and Administrative
53,287
63,336
36,292
14,875
Total Operating Expenses
89,506
95,964
79,305
50,726
Operating Income or Loss
-72,847
-81,923
-73,742
-50,726
Interest Expense
2,965
12,515
4,313
20
Total Other Income/Expenses Net
121,700
126,825
-33,657
-612
Income Before Tax
45,888
32,387
-111,712
-51,357
Income Tax Expense
2,303
536
1,771
-2,638
Income from Continuing Operations
43,585
31,851
-113,483
-48,719
Net Income
43,585
31,851
-113,483
-48,597
Net Income available to common shareholders
43,585
31,851
-113,483
-48,597
Reported EPS
Basic
-
0.69
-3.11
-2.26
Diluted
-
0.31
-3.11
-2.27
Weighted average shares outstanding
Basic
-
46,297
36,545
21,550
Diluted
-
49,725
36,545
21,656
EBITDA
-
52,089
-102,377
-51,327